Multispectral Optoacoustic Tomography for the ex vivo evaluation of pleural effusions

Multispectral Optoacoustic Tomography for the ex vivo evaluation of pleural effusions - MSOT_pleural effusion ex vivo

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00016715

Enrollment

Registered

2019-02-13

Start date

2019-05-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J90 J91

Interventions

Group 1: Pleural fluid from patients with transudate will be analyzed after removal by thoracocentesis using a onetime MSOT (multispectral optoacoustic tomography) ex vivo measurement. The inclusion o

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Already completed thoracocentesis; minimum age of 18 years

Exclusion criteria

Exclusion criteria: Minors (patients under the age of 18 years); pregnant patients

Design outcomes

Primary

Measure	Time frame
Comparison of MSOT (multispectral optoacoustic tomography) results for ex vivo pleural fluid of the groups “transudate”, “exudate”, and “hemorrhagic effusion”. The MSOT measurement after study inclusion will be performed at “Medizinische Klinik 1, Ulmenweg 18, 90154 Erlangen“.	—

Secondary

Measure	Time frame
If available, comparison of lab parameters and other diagnostic results with the MSOT (multispectral optoacoustic tomography) results after completion of the MSOT measurement.	—

Countries

Germany

Contacts

Public ContactIngo Ganzleben

Medizinische Klinik 1 University of Erlangen-Nürnberg

Ingo.Ganzleben at uk-erlangen.de04991318545161

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026